Episode

Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA

Podcast
The IMID Forum
Published
Jul 16, 2026
Duration seconds
1428
Processing state
not_requested
Canonical source
https://soundcloud.com/imidforum/discussing-axspa-long-term
Audio
https://feeds.soundcloud.com/stream/2361958505-imidforum-discussing-axspa-long-term.mp3
JSON
/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-axspa-long-term-safety-and-efficacy-of-bimekizumab-and-ixekizumab-in-r-axspa
Markdown
/podcast/the-imid-forum-981476/discussing-axspa-long-term-safety-and-efficacy-of-bimekizumab-and-ixekizumab-in-r-axspa.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-axspa-long-term-safety-and-efficacy-of-bimekizumab-and-ixekizumab-in-r-axspa/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-long-term-safety-and-efficacy-of-bimekizumab-and-ixekizumab-in-r-axspa.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA.